President Trump recently announced 100 percent tariffs on brand-name and patented medicines unless the manufacturer is also actively building a new plant in the United States. The policy will drive up prices for patients, create uncertainty in the market, and invite gamesmanship across the pharmaceutical industry.
Read Full Article »
